Cargando…
Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (NPM1) Mutation
Mutations in NPM1, also known as nucleophosmin-1, B23, NO38, or numatrin, are seen in approximately one-third of patients with acute myeloid leukaemia (AML). A plethora of treatment strategies have been studied to determine the best possible approach to curing NPM1-mutated AML. Here, we introduce th...
Autores principales: | Chin, Lynn, Wong, Chantelle Ye Gwen, Gill, Harinder |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958584/ https://www.ncbi.nlm.nih.gov/pubmed/36834572 http://dx.doi.org/10.3390/ijms24043161 |
Ejemplares similares
-
DNA damage corrects the aberrant cytoplasmic localisation of nucleophosmin in NPM1 mutated acute myeloid leukaemia
por: Bailey, Graham D., et al.
Publicado: (2019) -
Significance of nucleophosmin1 (NPM1) gene mutation status on acute myeloid leukaemia patients with normal karyotype in South India
por: Sureshkumar, R, et al.
Publicado: (2014) -
The Role of Nucleophosmin 1 (NPM1) Mutation in the Diagnosis and Management of Myeloid Neoplasms
por: Kelemen, Katalin
Publicado: (2022) -
Nucleophosmin1 (NPM1) abnormality in hematologic malignancies, and
therapeutic targeting of mutant NPM1 in acute myeloid leukemia
por: Chen, Yingyu, et al.
Publicado: (2020) -
Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia
por: Hirsch, Susanne, et al.
Publicado: (2017)